Navigation Links
Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
Date:6/4/2009

Thursday, June 11th, 10:00 a.m. EDT

WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, June 11th, 2009 at 10:00 a.m. EDT, to report fourth quarter and fiscal year 2009 financial results and to provide a quarterly update of the Company.

This call is being webcast by Thomson/CCBN and can be accessed via Repligen's website at www.repligen.com. If you are unable to access the webcast via the internet, you may also listen to the live broadcast by calling (800) 295-4740 for domestic calls and (617) 614-3925 for international calls. Participants must provide the following passcode: 30164372. For those who cannot participate in the live conference call, an archive of the audio webcast will be available shortly after the call and may be accessed at www.repligen.com.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
4. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
5. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
9. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
10. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
11. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ble in German . , Whether it,s CD packaging...adio Frequency Identification) are increasingly fi...ossible to label objects or goods and identify the...e scanner can read and process the data contained ... under production conditions of up to 100 degrees ...
(Date:11/24/2009)...Nov.24/PRNewswire/--Twomoreprestigiousuniversities...jobboardandcareerssiteforlifescienceprofessionals....ersofthejobboard,joining28othermajorlifesciencetra...rcenter.com ,isonlyforpost-graduatesinthelifescien...ntheInternet,BioCareerCenteristheonlyonethatserves...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in O... consistent growth during the U.S. recession. Howe...uble, and health systems are coming closer to havi...ust administrators. , (Vo...ontinued growing in October despite the shedding o...
(Date:11/24/2009)...RNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chine...dthe,investigationalnewdrugapplication(IND)foritso...ulationtotreatdiabetes.ThisIND,approvalallowsBiola...abetesisadisordercharacteristicofhighbloodglucosea...esultinseveremicro-and,macro-vasculardiseases,loss...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...neered metamaterial proved it can function as a st...ge of the electromagnetic spectrum, setting a stan...adiation, according to a team of researchers from ...l laboratories, and Boston University. , An elect...d structure of metallic split-ring resonators con...
... today announced the development of a unique film-...ue hydration to the passivation of medical device ... of patent-pending polymers that allow Particle Sc...ys Andrew Loxley, PS, Director of New Technologies...em to develop an ocular formulation for one of its...
...unched www.EyeScience.com to fill a large consum...n on age-related macular degeneration (AMD) in a u...essive, hereditary eye disease that is the leading... , , On the site, visitors can learn about basic ..., signs and symptoms and treatments for AMD. In ad...
Other Biology Technology:Team develops new metamaterial device 2Team develops new metamaterial device 3Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention 2
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)..., TORONTO, November 23, 2009 - The time of day ma...ing to a new paper produced by a research team led...nto Scarborough,s vice-principal for research and ...iology at the St. George campus. , Capitalizin...he poplar tree, the research team examined how pop...
(Date:11/23/2009)... Farmington, CT Current research suggests that a ...sease. The related report by Nichols et al, "Uniq...a New Class of TLR2 Ligands Capable of Enhancing A...f The American Journal of Pathology . , Multipl...m attacks the brain and spinal cord, affects nearl...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2FDA Approves NovoLog 28R 29 Labeling Update 51814 1FDA Approves NovoLog 28R 29 Labeling Update 51814 2FDA Approves NovoLog 28R 29 Labeling Update 51814 3FDA Approves NovoLog 28R 29 Labeling Update 51814 4Fraternal Order of Eagles Award 24630 000 in Grants at International Convention 51809 1Fraternal Order of Eagles Award 24630 000 in Grants at International Convention 51809 2Tube Feeding Error 3A Fatal Medical Mistakes 51804 1Tube Feeding Error 3A Fatal Medical Mistakes 51804 2Tube Feeding Error 3A Fatal Medical Mistakes 51804 3
...d the first clear example of how climate extremes ...ormally tolerated singly may converge and bring ab...ued June 25 by PLoS ONE, an online peer-reviewed...of canine distemper virus (CDV) in 1994 and 2001 t...eti lions. CDV cycles periodically within the Sere...
...K. have discovered that our own body not only make...ent in marijuana (THC), but these play an importa... on "endocannabinoids" just published online in, a... The FASEB Journal could lead to new drugs that t..., and even skin-related tumors. , "Our preclinic...
...rsity faculty member who uses computational techni...gs is attracting worldwide attention from other re...r of chemical and biomedical engineering at the Fl...ege of Engineering, is using high-powered computer... immunotoxins can best be modified in order to att...
Other Biology News:FSU researcher using computers to hone cancer-fighting strategies 2
Goat Anti-Derlin-2 (C-18) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Dynabeads M-450 Epoxy from Dynal Biotech
Goat Anti-DOCK 2 (E-15) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-HSV-2 gD Monoclonal Antibody, Unconjugated, Clone 0191 from Santa Cruz Biotechnology, Inc.
Biology Products: